CC BY-NC-ND 4.0 · Thorac Cardiovasc Surg 2022; 70(S 03): e15-e20
DOI: 10.1055/s-0042-1756493
DOI: 10.1055/s-0042-1756493
Pediatric and Congenital Cardiology
Risk Assessment of Red Cell Transfusion in Congenital Heart Disease
Authors
-
1 Department of Congenital Heart Disease and Pediatric Cardiology, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany
-
René Höhn
1 Department of Congenital Heart Disease and Pediatric Cardiology, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany -
David Hübner
2 Department of Machine Learning for Medical Applications, Averbis GmbH, Freiburg, Germany -
Markus Umhau
3 Institute for Transfusion Medicine and Gene Therapy, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany -
Johannes Kroll
4 Department of Cardiovascular Surgery, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany -
Fabian A. Kari
4 Department of Cardiovascular Surgery, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany -
Frank Humburger
5 Department of Anesthesiology and Critical Care, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany -
Sven Maier
4 Department of Cardiovascular Surgery, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany -
Brigitte Stiller
1 Department of Congenital Heart Disease and Pediatric Cardiology, University Heart Centre Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany